Cvfg LLC Buys New Holdings in Cardinal Health, Inc. $CAH

Cvfg LLC purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the first quarter, HoldingsChannel.com reports. The firm purchased 38,666 shares of the company’s stock, valued at approximately $8,171,000. Cardinal Health comprises 1.0% of Cvfg LLC’s holdings, making the stock its 23rd biggest holding.

A number of other large investors also recently modified their holdings of CAH. Integrated Wealth Concepts LLC raised its holdings in Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp lifted its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Cardinal Health during the second quarter worth approximately $1,935,000. Cerity Partners LLC raised its stake in shares of Cardinal Health by 17.0% in the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after acquiring an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC raised its stake in shares of Cardinal Health by 34.4% in the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after acquiring an additional 2,646 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.8%

Shares of Cardinal Health stock opened at $239.36 on Wednesday. The business has a 50-day moving average price of $210.43 and a 200 day moving average price of $212.35. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The firm has a market cap of $56.06 billion, a P/E ratio of 36.60, a P/E/G ratio of 1.17 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is currently 31.50%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Morgan Stanley increased their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Evercore lowered their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Wells Fargo & Company reduced their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, Citigroup reiterated a “buy” rating on shares of Cardinal Health in a research note on Thursday, July 2nd. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $247.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.